Webinar Date/Time: Tuesday, February 14th, 2023 at 10am EST|7am PST|3pm GMT|4pm CET
The modern trial strategies of today accommodate for a more modern, patient-focused approaches inclusive of the needs of sites and patients. In this webinar, IQVIA experts will share how we determine which solutions are proving to successfully optimize future trials by increasing patient centricity, improving recruitment outcomes with quality in mind and improving site efficiencies.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1592032&tp_key=9ebb5fb63f
Event Overview:
Several years prior to the pandemic, a handful of life sciences companies and clinical research organizations began dedicating resources and expertise to better address long-standing challenges in trial design and execution. Placing a premium on innovation, these sponsors and CROs looked at age-old problems in a new way, integrating novel, purpose-driven solutions and gauging how they help resolve specific challenges.
In this webinar, IQVIA experts will share how we determine which solutions are proving to successfully optimize future trials by increasing patient centricity, improving recruitment outcomes with quality in mind and improving site efficiencies.
Three Key Take-Aways:
Speakers:
Denise Messer, MA
Director, Design Analytics
IQVIA
Denise has over 25 years of experience in research and clinical trials, including expertise in clinical trial planning and design. She has spoken and published in industry journals on topics including assessing and scoring trial patient burden, highlighting the voice of the patient in trial design, and assessing protocol complexity. At IQVIA, she helped developed the IQVIA Data Informed Protocol Assessment, using data to highlight areas for protocol optimization before operationalization, including creation of a patient burden algorithm and protocol scoring benchmarks and co-founded the IQVIA Clinical Analytics and Simulations group to assist in country/site strategy building with advanced analytics modeling.
Ann Dokus
Sr. Director, Experience Optimization, Patient Centric Solutions and Decentralized Trials
IQVIA
Ann is an Experienced Technology Innovator with a long history in the biopharmaceuticals industry with big pharma (Pfizer) and boutique technology firms. She is professionally skilled in Business Planning, Operations Management, Clinical Research, IT Strategy, and Biotechnology and alongside her strengths in information technology, drive her passion to transform clinical trials through patient centricity, user experience and health IT.
Katie Shaw
Senior Director, Global Patient & Site Solutions
IQVIA
In her current role at IQVIA, Katie is accountable for the data-driven strategy development and operational pull-through for the Patient Recruitment & Enablement solutions. Katie leverages her 15 years of experience in the clinical research industry, specializing in patient recruitment and retention innovation in the areas of data science, technology, and patient engagement, and operational integration of IQVIA strategies, products, and services across the global multi-disciplinary teams, sites, and with customers who leverage IQVIA solutions.
Shawne Morgan
Global Head, Strategy and Development, Clinical Trial Educators
IQVIA
Shawne’s professional focus is centered around integrated innovation, diversity, patient recruitment and site enablement solutions. Over 23 years in the industry at IQVIA, Shawne supports a global team including over 300 medical professionals dedicated to driving outreach, training, start-up to accelerate timelines and recruitment across clinical programs. These “Trial Ambassadors” have proven results and metrics across all Therapeutic areas.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1592032&tp_key=9ebb5fb63f
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.